tiprankstipranks
TipRanksTop Financial ExpertsInsidersLux Venture Partners V, LLC

Lux Venture Partners V, LLC Insider Profile

4 Followers
Lux Venture Partners V, LLC, Ten Percent Owner at Eikon Therapeutics, Inc., holds 2.29M shares in Eikon Therapeutics, Inc. (Ticker: EIKN).
tipranks
Lux Venture Partners V, LLC

Lux Venture Partners V, LLC
Eikon Therapeutics, Inc. (EIKN)
Ten Percent Owner

Not Ranked
Lux Venture Partners V, LLC has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$33M
100.00%
A breakdown of Lux Venture Partners V, LLC's holdings

Insider Roles

Eikon Therapeutics, Inc.
(EIKN)
Ten Percent Owner
Roles that Lux Venture Partners V, LLC holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Lux Venture Partners V, LLC

Lux Venture Partners V, LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eikon Therapeutics, Inc.
Feb 06, 2026
Ten Percent Owner
Uninformative Buy
$33.27M
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 06, 2026
Uninformative Buy
$0.00
5,695,010
$0.00
Feb 06, 2026
Informative Buy
$5.00M
277,776
$18.00
List of latest transactions for each holding click on a transaction to see Lux Venture Partners V, LLC's performance on stock

Lux Venture Partners V, LLC insider profile FAQ

What is the percentage of profitable transactions made by Lux Venture Partners V, LLC?
The percentage of profitable transactions made by Lux Venture Partners V, LLC is ―.
    What is the average return per transaction made by Lux Venture Partners V, LLC?
    The average return per transaction made by Lux Venture Partners V, LLC is ―.
      What stocks does Lux Venture Partners V, LLC hold?
      Lux Venture Partners V, LLC holds: EIKN stocks.
        What was Lux Venture Partners V, LLC’s latest transaction?
        Lux Venture Partners V, LLC latest transaction was an Uninformative Buy of ―.
          What was Lux Venture Partners V, LLC's most profitable transaction?
          Lux Venture Partners V, LLC’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Lux Venture Partners V, LLC's role in Eikon Therapeutics, Inc.?
            Lux Venture Partners V, LLC's role in Eikon Therapeutics, Inc. is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.